Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Picard, Pierre ^a   Smith, Paula J W ^a   Monge, Juan C ^a   Rouleau, Jean L ^b   Nguyen, Quang T ^b   Calderone, Angelino ^b   Stewart, Duncan J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelin; Endothelin receptor antagonists; Heart failure; mRNA quantification; Rat

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; MESSENGER RNA; RIBONUCLEASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CONGESTIVE HEART FAILURE; HEART; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; UPREGULATION; WISTAR RAT;

ANIMALS; ENDOTHELIN-1; ENDOTHELINS; HEART; HEART FAILURE, CONGESTIVE; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RIBONUCLEASES; RNA, MESSENGER; UP-REGULATION;

EID: 0031629288     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00082     Document Type: Article

References (21)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Siegfried MR, Aoki N, Mulloy D, Lefer AM. Direct positive inotropic and vasoconstrictor effects of endothelin. Heart Vessels 1990;5:146-51.
3. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
4. Lariviere R, Sventek P, Thibault G, Schiffrin EL. Endothelin-1 expression in blood pressure of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Can J Physiol Pharmacol 1995;73:390-8.
5. Guarda E, Katwa LC, Myers PR, Tyagi S, Weber K. Effects of endothelin on collagen turnover in cardiac fibroblasts. Cardiovasc Res 1993;27:2130-4.
6. Han H, Neubauer B, Braeker B, Ertl G. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart. Attenuation of ischemic injury by the endothelin-1 antagonists BQ 123 and BQ 610. J Mol Cell Cardiol 1995;27:761-6.
7. Stewart DJ, Kubac G, Costello KB, Cernacek P. Increased plasma endothelin-1 in the early hour of acute myocardial infarction. J Am Coll Cardiol 1991;18:38-43.
8. Lee JY, Warner RB, Opgenorth TJ. Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat. Pharmacology 1994; 49:319-24.
9. Mertz TE, McClanahan TB, Flynn MA, et al. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs. J Pharmacol Exp Ther 1996;278:42-9.
10. Munter K, Hergenröder S, Unger L, Kirchengast M. Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm Pharmacol Lett 1996;6:90-2.
11. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
12. Prié S, Leung TK, Cernacek P, Ryan J, Dupuis J. Orally active ETA receptor antagonist LU135252 prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats. J Pharmacol Exp Ther [in press].
13. d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, Lüscher TF. Effects of chronic ETA-receptor blockade on angiotensin II-induced hypertension. Hypertension 1997;29:435-41.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Tonnessen T, Christensen G, Øie E, et al. Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats. Cardiovasc Res 1997;33:601-10.
16. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Circulation 1996;93:1214-22.
17. Huntington K, Picard P, Moe G, Albernaz A, Stewart DJ, Monge JC. Increased cardiac and pulmonary ET-1 mRNA expression in canine pacing induced heart failure. J Cardiovasc Pharmacol 1998;31(suppl 1):S424-6 (this issue).
18. Brown LA, Nunez DJ, Brookes CI, Wilkins MR. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Cardiovasc Res 1995;29:768-74.
19. B receptor antagonist. Circulation 1996;263:2068-79.
20. Nguyen QT, Cernacek, Stewart DJ, Picard P, White M, Rouleau JL. Endothelin-A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure postinfarction in the rat. Circulation [submitted].
21. Saito S, Hirata Y, Imai T, Marumo F. Autocrine regulation of the endothelin-1 gene in rat endothelial cells. J Cardiovasc Pharmacol 1995;26(suppl 3):S84-7.